MyOme ads

Take control of patient outcomes. Genome First provides clinicians with whole-genome insights to anticipate risks, prevent delays, and deliver personalized care for children with rare conditions.

Lead the way in Precision Medicine. Don’t wait for symptoms, start with the genome. MyOme’s Genome First approach delivers comprehensive genomic insights early, shaping more proactive, precise, and personalized care.

Don’t wait for symptoms to guide care. Genome First empowers clinicians to act early, uncover risks, and deliver personalized insights—so patients get answers faster.

Find answers faster. MyOme’s Genome First approach empowers clinicians to assess inherited risks and uncover rare disease diagnoses—delivering clarity and confidence for families at every stage of care.

Join MyOme and Danny Miller MD, PhD, FACMG, Assistant Professor at University of Washington, to explore how long-read sequencing and methylation can strengthen diagnostic yield and interpretation in rare disease. 📅 Oct 30 | 10AM PST / 1PM EST 🔗 Register here: https://lnkd.in/gUV9y793 Learn how these emerging tools enhance variant interpretation, clarify uncertain results, and support more precise care for families navigating rare conditions. #Genomics #RareDisease #Diagnostics

Clinicians can now uncover actionable insights from the very first visit. MyOme’s Genome First approach streamlines decision-making, enabling faster, smarter care tailored to each patient.